UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

Journal of cancer research and clinical oncology, 2013-02, Vol.139 (2), p.223-229

2013

Volltextzugriff (PDF)

Efficacy and safety of nivolumab for metastatic biliary tract cancer

OncoTargets and therapy, 2019-01, Vol.12, p.861-867

2019

Volltextzugriff (PDF)

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

BMC cancer, 2024-01, Vol.24 (1), p.67-67, Article 67

2024

Volltextzugriff (PDF)

Comparison of gut microbiota structure and Actinobacteria abundances in healthy young adults and elderly subjects: a pilot study

BMC microbiology, 2021-01, Vol.21 (1), p.13-13, Article 13

2021

Volltextzugriff (PDF)

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey

Nutrients, 2023-09, Vol.15 (17), p.3825

2023

Volltextzugriff (PDF)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

Frontiers in oncology, 2022-07, Vol.12, p.851756-851756

2022

Volltextzugriff (PDF)

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Frontiers in pharmacology, 2022-04, Vol.13, p.895187-895187

2022

Volltextzugriff (PDF)

LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4

Biomedicine & pharmacotherapy, 2020-05, Vol.125, p.109916-109916, Article 109916

2020

Volltextzugriff (PDF)

Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients

Frontiers in oncology, 2022-08, Vol.12, p.883514-883514

2022

Volltextzugriff (PDF)

PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis

Frontiers in oncology, 2021-06, Vol.11, p.648068-648068

2021

Volltextzugriff (PDF)

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

Frontiers in oncology, 2021-06, Vol.11, p.655716-655716

2021

Volltextzugriff (PDF)

A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies

Frontiers in oncology, 2022-02, Vol.11, p.798415-798415

2022

Volltextzugriff (PDF)

A research of 3D models for cloud-based technology combined with laser scanning close-range photogrammetry method

International journal of advanced manufacturing technology, 2023-11

2023

Volltextzugriff (PDF)

Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer

American journal of translational research, 2019-01, Vol.11 (5), p.3213-3225

2019

Volltextzugriff (PDF)

A phase II single-center single-arm study of PD-1 inhibitor in combination with albumin paclitaxel and apatinib as second-line treatment of metastatic gastric cancer (mGC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16024-e16024

2022

Volltextzugriff (PDF)

A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2024-06, Vol.24 (4), p.579-583

2024

Volltextzugriff (PDF)

Efficacy and safety of nivolumab in first-line or further treatment of advanced metastatic biliary tract cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.315-315

2019

Volltextzugriff (PDF)

Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study

Scientific reports, 2018-03, Vol.8 (1), p.4602-7, Article 4602

2018

Volltextzugriff (PDF)

Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and hemoglobin (Hb) predict immunotherapy outcomes in patients with advanced or metastatic gastric cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16075-e16075

2021

Volltextzugriff (PDF)

Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment

Archiv der Pharmazie (Weinheim), 2022-09, Vol.355 (9), p.e2200106-n/a

2022

Volltextzugriff (PDF)

Efficacy and safety of immune checkpoint inhibitors combined with anti-VEGF therapy in the treatment of unresectable or advanced liver cancer: a systematic review

Immunopharmacology and immunotoxicology, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Volltextzugriff (PDF)

Pd-1 inhibitors plus nab-paclitaxel with S1 (AS) as first line in patients with advanced biliary tract cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15195-e15195

2020

Volltextzugriff (PDF)

Apatinib combined with Raltitrexed in patients with metastatic colorectal cancer after failure of standard therapy (AHEAD-311): A single-arm phrase II pilot trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15008-e15008

2019

Volltextzugriff (PDF)

A phase 1b/2 study of surufatinib plus camrelizumab, nab-paclitaxel, and S-1 (NASCA) as first-line therapy for metastatic pancreatic adenocarcinoma (mPDAC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4142-4142

2023

Volltextzugriff (PDF)

Fruquintinib combination with sintilimab in refractory metastatic colorectal cancer patients in China

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4028-4028

2020

Volltextzugriff (PDF)

1 – 25 von 369

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(334)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(132)
Technology
(100)
Physical Sciences
(75)
Materials Science
(56)
Chemistry
(54)
Materials Science, Multidisciplinary
(52)
Humans
(47)
Engineering
(38)
Science & Technology - Other Topics
(34)
Chemistry, Physical
(29)
Chemistry, Multidisciplinary
(22)
Nanoscience & Nanotechnology
(22)
Oncology
(22)
Physics
(22)
Female
(20)
Animals
(17)
Biochemistry & Molecular Biology
(17)
Engineering, Electrical & Electronic
(17)
Physics, Applied
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

Efficacy and safety of nivolumab for metastatic biliary tract cancer

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Comparison of gut microbiota structure and Actinobacteria abundances in healthy young adults and elderly subjects: a pilot study

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials

LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4

Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients

PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies

A research of 3D models for cloud-based technology combined with laser scanning close-range photogrammetry method

Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer

A phase II single-center single-arm study of PD-1 inhibitor in combination with albumin paclitaxel and apatinib as second-line treatment of metastatic gastric cancer (mGC)

A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer

Efficacy and safety of nivolumab in first-line or further treatment of advanced metastatic biliary tract cancer

Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study

Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and hemoglobin (Hb) predict immunotherapy outcomes in patients with advanced or metastatic gastric cancer

Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment

Efficacy and safety of immune checkpoint inhibitors combined with anti-VEGF therapy in the treatment of unresectable or advanced liver cancer: a systematic review

Pd-1 inhibitors plus nab-paclitaxel with S1 (AS) as first line in patients with advanced biliary tract cancer

Apatinib combined with Raltitrexed in patients with metastatic colorectal cancer after failure of standard therapy (AHEAD-311): A single-arm phrase II pilot trial

A phase 1b/2 study of surufatinib plus camrelizumab, nab-paclitaxel, and S-1 (NASCA) as first-line therapy for metastatic pancreatic adenocarcinoma (mPDAC)

Fruquintinib combination with sintilimab in refractory metastatic colorectal cancer patients in China

Suchergebnisse filtern